187 related articles for article (PubMed ID: 7247126)
1. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
[TBL] [Abstract][Full Text] [Related]
2. Development of pharmacodynamic tolerance to prozosin in congestive heart failure.
Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV
Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512
[TBL] [Abstract][Full Text] [Related]
3. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure.
Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH
Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894
[TBL] [Abstract][Full Text] [Related]
4. Comparison of haemodynamic effects of oral hydralazine and prazosin hydrochloride in patients with chronic congestive heart failure.
Chatterjee K; Ports TA; Arnold S; Brundage B; Parmley W
Br Heart J; 1979 Dec; 42(6):657-63. PubMed ID: 534582
[TBL] [Abstract][Full Text] [Related]
5. Hydralazine and isosorbide dinitrate: comparative central and regional hemodynamic effects when administered alone or in combination.
Leier CB; Magorien RD; Desch CE; Thompson MJ; Unverferth DV
Circulation; 1981 Jan; 63(1):102-9. PubMed ID: 7438384
[TBL] [Abstract][Full Text] [Related]
6. The relationship between drug-induced changes in central and regional hemodynamics in congestive heart failure.
Cotsamire DL; Unverferth DV; Leier CV
Can J Cardiol; 1986; 2(5):272-7. PubMed ID: 3768787
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure.
Good AP; Unverferth DV; Leier CV
Cardiovasc Drugs Ther; 1988 Jan; 1(5):529-34. PubMed ID: 2908715
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of afterload reduction therapy in patients with congestive heart failure and moderate aortic stenosis.
Greenberg BH; Massie BM
Circulation; 1980 Jun; 61(6):1212-6. PubMed ID: 7371134
[No Abstract] [Full Text] [Related]
9. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure.
Mehta J; Iacona M; Feldman RL; Pepine CJ; Conti CR
Am J Cardiol; 1978 May; 41(5):925-30. PubMed ID: 645603
[No Abstract] [Full Text] [Related]
10. Attenuation of prazosin effect on cardiac output in chronic heart failure.
Arnold SB; Williams RL; Ports TA; Baughman RA; Benet LZ; Parmley WW; Chatterjee K
Ann Intern Med; 1979 Sep; 91(3):345-9. PubMed ID: 475164
[TBL] [Abstract][Full Text] [Related]
11. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure.
Elkayam U; Lejemtel TH; Mathur M; Ribner HS; Frishman WH; Strom J; Sonnenblick EH
Am J Cardiol; 1979 Sep; 44(3):540-5. PubMed ID: 474434
[No Abstract] [Full Text] [Related]
12. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
[TBL] [Abstract][Full Text] [Related]
13. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
[No Abstract] [Full Text] [Related]
14. Variable hemodynamic response to oral hydralazine in patients with refractory congestive heart failure.
LeJemtel TH; Elkayam U; Ribner HS; Hellman C; Strom J; Frishman W; Strobeck J; Sonnenblick EH
Eur Heart J; 1980 Jun; 1(3):157-63. PubMed ID: 7026250
[No Abstract] [Full Text] [Related]
15. Alterations in left ventricular function and coronary hemodynamics with captopril, hydralazine and prazosin in chronic ischemic heart failure: a comparative study.
Rouleau JL; Chatterjee K; Benge W; Parmley WW; Hiramatsu B
Circulation; 1982 Apr; 65(4):671-8. PubMed ID: 7037220
[No Abstract] [Full Text] [Related]
16. Positive inotropic effects of hydralazine in human subjects: comparison with prazosin in the setting of congestive heart failure.
Leier CV; Desch CE; Magorien RD; Triffon DW; Unverferth DV; Boudoulas H; Lewis RP
Am J Cardiol; 1980 Dec; 46(6):1039-44. PubMed ID: 7446418
[TBL] [Abstract][Full Text] [Related]
17. Systemic and regional hemodynamic effects of acute and prolonged treatment with urapidil or prazosin in normotensive and spontaneously hypertensive rats.
Pegram BL; Kobrin I; Natsume T; Gallo AJ; Frohlich ED
Am J Med; 1984 Oct; 77(4A):64-73. PubMed ID: 6486158
[TBL] [Abstract][Full Text] [Related]
18. Hydralazine in chronic CHF.
Chatterjee K; Rouleau JL; Massie BM
Acta Med Scand Suppl; 1981; 652():99-113. PubMed ID: 6949469
[TBL] [Abstract][Full Text] [Related]
19. Hydralazine therapy in chronic congestive heart failure. Sustained central and regional hemodynamic responses.
Magorien RD; Unverferth DV; Leier CV
Am J Med; 1984 Aug; 77(2):267-74. PubMed ID: 6431812
[TBL] [Abstract][Full Text] [Related]
20. Beneficial hemodynamic response to chronic prazosin therapy in congestive heart failure.
Feldman RC; Ball RM; Winchester MA; Jaillon P; Kates RE; Harrison DC
Am Heart J; 1981 May; 101(5):534-40. PubMed ID: 7223593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
